Login Register Cart 0
Generic placeholder image

Current Traditional Medicine

Editor-in-Chief

ISSN (Print): 2215-0838
ISSN (Online): 2215-0846

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

A Recent Update on Ayurvedic Anti-asthmatic Formulations: Highlighting the Role of Major Anti-asthmatic Plants

Author(s): Manisha Bhatia, Jasmine Chaudhary*, Akash Jain, Sonam, Ashwani Dhingra and Bhawna Chopra

Volume 10, Issue 6, 2024

Published on: 03 August, 2023

Article ID: e220623218154 Pages: 12

DOI: 10.2174/2215083810666230622111859

Price: $65

Abstract

Asthma is a chronic heterogeneous airway obstruction disorder defined by a complex cascade of pathophysiological conditions that lead to recurring bronchial hyper-responsiveness and underlying inflammation, lowering the patient’s quality of life. Despite the availability of various synthetic medications for the management of asthma, it has become one of the leading causes of death worldwide. Furthermore, the present allopathic treatment possesses severe long-term negative effects, which make people more attracted to the safer and easily available indigenous traditional and Ayurvedic system of medicine. Ayurveda is regarded as the “Mother of all healing” and “Science of Life,” which treats all the ailments, including asthma, by restoring a balance between three main components of the body- Vata, Pitta, and Dosha. Various clinically effective and less toxic anti- asthmatic Ayurvedic herbal preparations are available for the management of asthma and related complications which act by causing mast cell deactivation, inhibition of Th1, Th2, Th7 response, Tcell suppression, etc., therefore, efforts have been made to compile all the relevant literature related to the ayurvedic anti-asthmatic formulations and scrutinize the efficacy of selected plants present in the majority in those formulations in asthma along with the structure and mode of action of phytoconstituent responsible for designing novel molecules with better efficacy. Research on these selected plants can also have economic significance as various constituents isolated from these plants for their anti-asthmatic effect can further be explored to discover their potential in medicinal, diagnostic and cosmetic field.

Graphical Abstract

[1]
Cevhertas L, Ogulur I, Maurer DJ, et al. Advances and recent developments in asthma in 2020. Allergy 2020; 75(12): 3124-46.
[http://dx.doi.org/10.1111/all.14607] [PMID: 32997808]
[2]
Bousquet J, Clark TJH, Hurd S, et al. GINA guidelines on asthma and beyond. Allergy 2007; 62(2): 102-12.
[http://dx.doi.org/10.1111/j.1398-9995.2006.01305.x] [PMID: 17298416]
[3]
Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med 2006; 355(21): 2226-35.
[http://dx.doi.org/10.1056/NEJMra054308] [PMID: 17124020]
[4]
Dharmage SC, Perret JL, Custovic A. Epidemiology of asthma in children and adults. Front Pediatr 2019; 7: 246.
[http://dx.doi.org/10.3389/fped.2019.00246] [PMID: 31275909]
[5]
Liu F, Xuan NX, Ying SM, Li W, Chen ZH, Shen HH. Herbal medicines for asthmatic inflammation: From basic researches to clinical applications. Mediators Inflamm 2016; 2016: 6943135.
[http://dx.doi.org/10.1155/2016/6943135] [PMID: 27478309]
[6]
Prasad R, Lawania RD. Manvi, Gupta G. Role of herbs in the management of asthma. Phcog Rev 2009; 3(6): 247-58.
[7]
Ladde SK. Shalam. (2012) A short review on management of asthma through alternative therapies. Int J LifeSc Bt Pharm Res 2012; 1(1): 16-26.
[8]
Subbarao P, Mandhane PJ, Sears MR. Asthma: epidemiology, etiology and risk factors. CMAJ 2009; 181(9): E181-90.
[http://dx.doi.org/10.1503/cmaj.080612] [PMID: 19752106]
[9]
Ricciardolo FLM, Levra S, Sprio AE, et al. Asthma in the real-world: The relevance of gender. Int Arch Allergy Immunol 2020; 181(6): 462-6.
[http://dx.doi.org/10.1159/000506808] [PMID: 32203959]
[10]
Barnes PJ. Cytokine modulators as novel therapies for asthma. Annu Rev Pharmacol Toxicol 2002; 42(1): 81-98.
[http://dx.doi.org/10.1146/annurev.pharmtox.42.111901.111143] [PMID: 11807165]
[11]
Parasuraman S, Thing GS, Dhanaraj SA. Polyherbal formulation: Concept of ayurveda. Pharmacogn Rev 2014; 8(16): 73-80.
[http://dx.doi.org/10.4103/0973-7847.134229] [PMID: 25125878]
[12]
Pandey MM, Rastogi S, Rawat AKS. Indian traditional ayurvedic system of medicine and nutritional supplementation. Evid Based Complement Alternat Med 2013; 2013: 376327.
[http://dx.doi.org/10.1155/2013/376327] [PMID: 23864888]
[13]
Jaiswal YS, Williams LL. A glimpse of Ayurveda-The forgotten history and principles of Indian traditional medicine. J Tradit Complement Med 2016; 7(1): 50-3.
[http://dx.doi.org/10.1016/j.jtcme.2016.02.002] [PMID: 28053888]
[14]
Kumar S, Dobos GJ, Rampp T. The significance of Ayurvedic medicinal plants. J Evid Based Complementary Altern Med 2017; 22(3): 494-501.
[http://dx.doi.org/10.1177/2156587216671392] [PMID: 27707902]
[15]
Yadav V, Krishnan A, Vohora D. A systematic review on Piper longum L.: Bridging traditional knowledge and pharmacological evidence for future translational research. J Ethnopharmacol 2020; 247: 112255.
[http://dx.doi.org/10.1016/j.jep.2019.112255] [PMID: 31568819]
[16]
Bagci E, Yazgın A, Hayta S, Cakılcıoglu U. Composition of the essential oil of Teucrium chamaedrys L. (Lamiaceae) from Turkey. J Med Plants Res 2010; 4(23): 2588-90.
[17]
Choudhary N, Singh V. Piper longum: A review of its phytochemicals and their network pharmacological evaluation. PLoS One 2017; 1-38.
[http://dx.doi.org/10.1101/169763]
[18]
Gani HMO, Hoq MO, Tamanna T. Ethnomedicinal, phytochemical and pharmacological properties of Piper longum (Linn). Asian J Med Biol Res 2019; 5(1): 1-7.
[http://dx.doi.org/10.3329/ajmbr.v5i1.41038]
[19]
Biswas P, Ghorai M, Mishra T, et al. Piper longum L.: A comprehensive review on traditional uses, phytochemistry, pharmacology, and health-promoting activities. Phytother Res 2022; 36(12): 4425-76.
[http://dx.doi.org/10.1002/ptr.7649] [PMID: 36256521]
[20]
Kumari M, Ashok BK, Ravishankar B, Pandya TN, Acharya R. Anti-inflammatory activity of two varieties of Pippali (Piper longum Linn.). Ayu 2012; 33(2): 307-10.
[http://dx.doi.org/10.4103/0974-8520.105258] [PMID: 23559810]
[21]
Rajendra HM, Lad MD. A critical review on Pippali (Piper longum Linn.). Int J Ayu Pharm Chem 2016; 4(3): 1-9.
[22]
Choudhary GP. Mast cell stabilizing activity of Piper longum Linn. Indian J Allergy Asthma Immunol 2006; 20(2): 112-6.
[23]
Kim SH, Lee YC. Piperine inhibits eosinophil infiltration and airway hyperresponsiveness by suppressing T cell activity and Th2 cytokine production in the ovalbumin-induced asthma model. J Pharm Pharmacol 2009; 61(3): 353-9.
[http://dx.doi.org/10.1211/jpp.61.03.0010] [PMID: 19222908]
[24]
Kaushik D, Rani R, Kaushik P, Sacher D, Yadav J. In-vivo and in-vitro antiasthmatic studies of plant Piper longum Linn. Int J Pharmacol 2012; 8(3): 192-7.
[http://dx.doi.org/10.3923/ijp.2012.192.197]
[25]
Dhanukar SA, Karandikar SM, Desai M. Efficacy of Piper longum in childhood asthma. Indian Drugs 1984; 21(9): 384-8.
[26]
Clark CE, Arnold E, Lasserson TJ, Wu T. Herbal interventions for chronic asthma in adults and children: A systematic review and meta-analysis. Prim Care Respir J 2010; 19(4): 307-14.
[http://dx.doi.org/10.4104/pcrj.2010.00041] [PMID: 20640388]
[27]
Bui TT, Piao CH, Song CH, Shin HS, Shon DH, Chai OH. Piper nigrum extract ameliorated allergic inflammation through inhibiting Th2/Th17 responses and mast cells activation. Cell Immunol 2017; 322: 64-73.
[http://dx.doi.org/10.1016/j.cellimm.2017.10.005] [PMID: 29066080]
[28]
Lu C, Zhang B, Xu T, et al. Piperlongumine reduces ovalbumin induced asthma and airway inflammation by regulating nuclear factor κB activation. Int J Mol Med 2019; 44(5): 1855-65.
[http://dx.doi.org/10.3892/ijmm.2019.4322] [PMID: 31485644]
[29]
Kumar KPS, Bhowmik D. Chiranjib, Tiwari P, Kharel R. Indian traditional herbs Adhatoda vasica and its medicinal application. J Chem Pharm Res 2010; 2(1): 240-5.
[30]
Arora P. Importance of Adhatoda vasica Nees in traditional system of medicines: A review. Am J PharmTech Res 2019; 9(2): 85-93.
[http://dx.doi.org/10.46624/ajptr.2019.v9.i2.009]
[31]
Khan R, Shamsi Y, Nikhat S. Medicinal benefits of Adhatoda vasica nees - In Unani and Contemporary medicine. Cell Med 2020; 10(2): 1-7.
[http://dx.doi.org/10.5667/CellMed.2020.0013]
[32]
Tahmida S, Muhammad SA, Junaid , et al. Adhatoda vasica (Nees.): A review on its botany, traditional uses, phyto-chemistry, pharmacological activities and toxicity. Mini Rev Med Chem 2021; 14(2): 1925-64.
[http://dx.doi.org/10.2174/1389557521666210226152238]
[33]
Chaudry NT, Nasreen S, Ihsan I. Bronchial asthma; Effect of Adhatoda vasica on airways responsiveness with pulmonary function test. Prof Med J 2005; 12(3): 327-30.
[http://dx.doi.org/10.29309/TPMJ/2005.12.03.5131]
[34]
Hossain MT, Hoq MO. Therapeutic use of Adhatoda vasica. Asian J Med Biol Res 2016; 2(2): 156-63.
[http://dx.doi.org/10.3329/ajmbr.v2i2.29005]
[35]
Rayees S, Mabalirajan U, Bhat WW, et al. Therapeutic effects of R8, a semi-synthetic analogue of Vasicine, on murine model of allergic airway inflammation via STAT6 inhibition. Int Immunopharmacol 2015; 26(1): 246-56.
[http://dx.doi.org/10.1016/j.intimp.2015.03.035] [PMID: 25863236]
[36]
Rayees S, Satti NK, Mehra R, et al. Anti-asthmatic activity of azepino[2, 1-b]quinazolones, synthetic analogues of vasicine, an alkaloid from Adhatoda vasica. Med Chem Res 2014; 23(9): 4269-79.
[http://dx.doi.org/10.1007/s00044-014-0996-y]
[37]
Dangi A, Patel S, Yaduvanshi PS. Phytochemical screening and assessment of Adhatoda vasica (leaf) for antiasthmatic activity. Panacea J Pharm Pharm Sci 2015; 4(3): 680-704.
[38]
Gheware A, Panda L, Khanna K, et al. Adhatoda vasica rescues the hypoxia-dependent severe asthma symptoms and mitochondrial dysfunction. Am J Physiol Lung Cell Mol Physiol 2021; 320(5): L757-69.
[http://dx.doi.org/10.1152/ajplung.00511.2020] [PMID: 33565386]
[39]
Wahab S, Annadurai S, Abullais SS, et al. Glycyrrhiza glabra (Licorice): A comprehensive review on its phytochemistry, biological activities, clinical evidence and toxicology. Plants 2021; 10(12): 2751.
[http://dx.doi.org/10.3390/plants10122751] [PMID: 34961221]
[40]
El-Saber Batiha G, Magdy Beshbishy A, El-Mleeh A, Abdel-Daim MM, Prasad Devkota H. Traditional uses, bioactive chemical constituents, and pharmacological and toxicological activities of Glycyrrhiza glabra L. (Fabaceae). Biomolecules 2020; 10(3): 352.
[http://dx.doi.org/10.3390/biom10030352] [PMID: 32106571]
[41]
Ram A, Mabalirajan U, Das M, et al. Glycyrrhizin alleviates experimental allergic asthma in mice. Int Immunopharmacol 2006; 6(9): 1468-77.
[http://dx.doi.org/10.1016/j.intimp.2006.04.020] [PMID: 16846841]
[42]
Patel S, Saxena N, Saxena RC, Arya N, Saxena R, Tharani M. Evaluation of anti-asthmatic activity of Glycyrrhiza glabra. Biosci Biotechnol Res Asia 2009; 6(2): 761-6.
[43]
Hocaoglu AB, Karaman O, Erge DO, et al. Glycyrrhizin and long-term histopathologic changes in a murine model of asthma. Curr Ther Res Clin Exp 2011; 72(6): 250-61.
[http://dx.doi.org/10.1016/j.curtheres.2011.11.002] [PMID: 24648593]
[44]
Hassan Kha HAE-R, Abdel-Daye UA. AbdulSalam H, Tallat Abb A, Ahmead Abd MT, El-Aziz Fo NA. Licorice (Glycyrrhizza glabra) extract prevents production of Th2 cytokines and free radicals induced by ova albumin in mice. Int J Pharmacol 2018; 14(8): 1072-9.
[http://dx.doi.org/10.3923/ijp.2018.1072.1079]
[45]
Sadek E, Tawfik N, Hussein A, Abdelhakeem M. Efficacy and safety of liquorice extract in asthmatic patients. J Adv Biomed Pharm Sci 2019; 2(2): 54-8.
[http://dx.doi.org/10.21608/jabps.2019.6609.1030]
[46]
Fouladi S, Masjedi M, Ganjalikhani Hakemi M, Eskandari N. The review of in vitro and in vivo studies over the glycyrrhizic acid as natural remedy option for the treatment of allergic asthma. Iran J Allergy Asthma Immunol 2019; 18(1): 1-11.
[http://dx.doi.org/10.18502/ijaai.v18i1.626] [PMID: 30848569]
[47]
Kizhakkayil J, Sasikumar B. Diversity, characterization and utilization of ginger: A review. Plant Genet Resour 2011; 9(3): 464-77.
[http://dx.doi.org/10.1017/S1479262111000670]
[48]
Kardan M, Rafiei A, Ghaffari J, Valadan R, Morsaljahan Z, Haj-Ghorbani ST. Effect of ginger extract on expression of GATA3, T-bet and ROR-γt in peripheral blood mononuclear cells of patients with Allergic Asthma. Allergol Immunopathol (Madr) 2019; 47(4): 378-85.
[http://dx.doi.org/10.1016/j.aller.2018.12.003] [PMID: 30745246]
[49]
Yocum GT, Hwang JJ, Mikami M, Danielsson J, Kuforiji AS, Emala CW. Ginger and its bioactive component 6-shogaol mitigate lung inflammation in a murine asthma model. Am J Physiol Lung Cell Mol Physiol 2020; 318(2): L296-303.
[http://dx.doi.org/10.1152/ajplung.00249.2019] [PMID: 31800263]
[50]
Khan AM, Shahzad M, Raza Asim MB, Imran M, Shabbir A. Zingiber officinale ameliorates allergic asthma via suppression of Th2-mediated immune response. Pharm Biol 2015; 53(3): 359-67.
[http://dx.doi.org/10.3109/13880209.2014.920396] [PMID: 25420680]
[51]
Rouhi H. Forouzan Ganji, Hamid Nasri. Effects of ginger on the improvement of asthma. Pak J Nutr 2006; 5(4): 373-6.
[http://dx.doi.org/10.3923/pjn.2006.373.376]
[52]
Rout S, Dutta S, Rath B. Evaluation of broncho-protective effect of Zingiber officinale Roscoe in histamine induced broncho-spasm. Research J Pharm and Tech 2010; 3(2): 589-91.
[53]
Vaghela JH, Vadgama VK, Purohit BM. Bronchodilatory effect of Zingiber officinale Roscoe (ginger) in guinea pigs. Trop J Pharm Res 2020; 19(4): 845-9.
[http://dx.doi.org/10.4314/tjpr.v19i4.24]
[54]
Townsend EA, Siviski ME, Zhang Y, Xu C, Hoonjan B, Emala CW. Effects of ginger and its constituents on airway smooth muscle relaxation and calcium regulation. Am J Respir Cell Mol Biol 2013; 48(2): 157-63.
[http://dx.doi.org/10.1165/rcmb.2012-0231OC] [PMID: 23065130]
[55]
Joghee S, Joghee S, Akaash M. Solanum xanthocarpum: A review. Int J Pharmacogn Chin Med 2019; 3(3): 1-7.
[http://dx.doi.org/10.23880/ipcm-16000177]
[56]
Laware SG, Shirole NL. A systematic review on Solanum xanthocarpum L. (Solanaceae) plant and its potential pharmacological activities. IRJPS 2022; 13(2): 1-9.
[http://dx.doi.org/10.14303/irjps.2022.008]
[57]
Reddy NM, Reddy NR. Solanum xanthocarpum chemical constituents and medicinal properties: A review. Sch Acad J Pharm 2014; 3(2): 146-9.
[58]
Kajaria D, Tripathi JS, Tiwari SK. Study of antiasthmatic properties and chemical characterization of indigenous ayurvedic compounds (Polyherbal formulations). Am J Phytomed Clin Therapeut 2013; 1(6): 457-66.
[59]
Choudhary PK, Khandelwal V. Comprehensive phytopharmaceutical overview of Solanum xanthocarpum. Bull Env Pharmacol Life Sci 2020; 9(5): 153-9.
[60]
Govindan S, Viswanathan S, Vijayasekaran V, Alagappan R. A pilot study on the clinical efficacy of Solanum xanthocarpum and Solanum trilobatum in bronchial asthma. J Ethnopharmacol 1999; 66(2): 205-10.
[http://dx.doi.org/10.1016/S0378-8741(98)00160-3] [PMID: 10433479]
[61]
Govindan S, Viswanathan S, Vijayasekaran V, Alagappan R. Further studies on the clinical efficacy of Solanum xanthocarpum and Solanum trilobatum in bronchial asthma. Phytother Res 2004; 18(10): 805-9.
[http://dx.doi.org/10.1002/ptr.1555] [PMID: 15551394]
[62]
Vadnere GP, Gaud RS, Singhai AK. Evaluation of anti-asthmatic property of Solanum xanthocarpum flower extracts. Pharmacology 2008; 1: 513-22.
[63]
Parmar SK, Gangwal AP, Prajapati TR, Pandya KB, Ranpariya VL, Sheth NR. Evaluation of anti-asthmatic activity of ethanolic extract of Solanum xanthocarpum leaves. Pharmacologyonline 2010; 2: 410-24.
[64]
Gurav TP, Dholakia BB, Giri AP. A glance at the chemodiversity of Ocimum species: Trends, implications, and strategies for the quality and yield improvement of essential oil. Phytochem Rev 2022; 21(3): 879-913.
[http://dx.doi.org/10.1007/s11101-021-09767-z] [PMID: 34366748]
[65]
Prakash P, Gupta N. Therapeutic uses of Ocimum sanctum Linn (Tulsi) with a note on eugenol and its pharmacological actions: A short review. Indian J Physiol Pharmacol 2005; 49(2): 125-31.
[PMID: 16170979]
[66]
Singh S, Agrawal SS. Anti-asthmatic and anti-inflammatory activity of Ocimum sanctum. Int J Pharmacogn 1991; 29(4): 306-10.
[http://dx.doi.org/10.3109/13880209109082904]
[67]
Choudhary GP. Mast cell stabilizing activity of Ocimum sanctum leaves. Int J Pharm Bio Sci 2010; 1(2): 1-11.
[68]
Vinaya M, Kudagi BL, Kamdod MA, Swamy M. Bronchodilator activity of Ocimum sanctum Linn. (tulsi) in mild and moderate asthmatic patients in comparison with salbutamol: A single-blind cross-over study. Int J Basic Clin Pharmacol 2017; 6(3): 511-7.
[http://dx.doi.org/10.18203/2319-2003.ijbcp20170543]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy